Does Oregon Medicaid Cover Wegovy or Zepbound?
Oregon (OR) GLP-1 access depends on three state-specific policy questions before it ever gets to pricing: does Oregon Medicaid cover weight-loss GLP-1s, has Oregon expanded Medicaid under the ACA, and does the state employee health plan cover them. Answering those first tells you whether you're likely working with insurance or planning for cash-pay.
Oregon Medicaid GLP-1 coverage: what the state's own documents say
Oregon Health Plan does not cover drugs prescribed for weight loss for adults 21 and older (OAR 410-121-0147); Wegovy, Zepbound and Saxenda are covered only for other indications (type 2 diabetes, Wegovy for established cardiovascular disease or MASH, Zepbound for moderate-to-severe sleep apnea with obesity), and members under 21 get case-by-case review under EPSDT.
Checked September 20, 2026 against: secure.sos.state.or.us, orpdl.org, orpdl.org.
Oregon state employee health plan: what the plan's own documents say
Oregon's Public Employees' Benefit Board plans exclude weight-loss drugs: Moda's 2026 PEBB Synergy handbook (effective January 1, 2026) lists 'Weight Loss Medications' among the medications and supplies that are not covered. The Board's 2027 plan decisions (July 7, 2026 meeting) list no weight-loss drug change, though the Kaiser and Providence 2026 plan documents were not reviewed.
Checked September 20, 2026 against: modahealth.com, oregon.gov.
Notable insurers active in Oregon (not independently verified): Regence Blue Cross Blue Shield, Kaiser Permanente, Providence Health Plan.
Why GLP-1 coverage varies this much by state
Medicaid is a state-federal partnership, not a single national program. Each state Medicaid agency sets its own preferred drug list (PDL) and prior-authorization criteria within federal minimum requirements. Weight-loss drugs are not a federally mandated Medicaid benefit, so states choose independently whether to cover them - which is why only 10 of 50 states currently do (Oregon is not one of them).
State employee health plans are a useful bellwether. These plans cover hundreds of thousands of state workers and negotiate directly with pharmacy benefit managers, so their coverage decisions often signal where commercial insurers in that state are heading. North Carolina's State Health Plan, for example, ended coverage of weight-loss GLP-1s on April 1, 2024, after its board voted 4-3 to cut it citing the drugs' high cost - a case that other states and large employers have watched closely.
Medicaid expansion status shapes who even has coverage to begin with. States that haven't adopted ACA Medicaid expansion have narrower Medicaid eligibility overall, which - combined with the weight-loss GLP-1 exclusion most states apply regardless of expansion status - pushes a larger share of residents in those states toward commercial insurance, telehealth, or manufacturer self-pay as their only realistic path.
National reference pricing (same nationwide - your actual cost depends on your plan)
These prices are the same across all 50 states because manufacturer list prices, self-pay programs, and telehealth pricing don't vary by state - only insurance coverage and copay do, which is why the Oregon-specific policy facts above matter more than the table below for predicting your actual cost.
| Drug | Covered by insurance | Manufacturer self-pay | Telehealth | Cash retail |
|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $1,349 |
| Ozempic 11.6% weight loss | $63 | - | $399 | $1,028 |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 | $449 | $1,349 |
| Zepbound 22.5% weight loss | $88 | $299 | $499 | $1,059 |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $1,069 |
| Saxenda 8.4% weight loss | $63 | - | $399 | $1,349 |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 | - | $1,099 |
| CagriSema 20.4% weight loss | $88 | $599 | - | $1,499 |
Cheapest cash-pay GLP-1 paths for Oregon residents
Manufacturer direct prices (LillyDirect, NovoCare) are usually cheapest. Updated May 2026.
| Drug | Insurance | Mfr direct | Telehealth (brand) | Telehealth (compd) | Cash retail | Get it |
|---|---|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $249 cheapest | $1,349 | Get →ad |
| Ozempic 11.6% weight loss | $63 | - | $399 | $199 cheapest | $1,028 | Get →ad |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 cheapest | $449 | - | $1,349 | Get →ad |
| Zepbound 22.5% weight loss | $88 | $299 cheapest | $499 | $299 cheapest | $1,059 | Get →ad |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $299 cheapest | $1,069 | Get →ad |
| Saxenda 8.4% weight loss | $63 | - | $399 cheapest | - | $1,349 | Get →ad |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 cheapest | - | - | $1,099 | Get →ad |
Oregon carrier coverage details
National carriers active in Oregon (this list is not independently verified). Drill into each carrier's prior-auth requirements, formulary, and appeal playbook.
Frequently asked questions
Does Oregon Medicaid cover Wegovy or Zepbound for weight loss?
No. Oregon Health Plan does not cover drugs prescribed for weight loss for adults 21 and older (OAR 410-121-0147); Wegovy, Zepbound and Saxenda are covered only for other indications (type 2 diabetes, Wegovy for established cardiovascular disease or MASH, Zepbound for moderate-to-severe sleep apnea with obesity), and members under 21 get case-by-case review under EPSDT. This was checked against Oregon's own documents on September 20, 2026; coverage rules change often, so confirm with your plan before relying on it. Coverage for type 2 diabetes (Ozempic, Mounjaro) is a separate question. Medicare's GLP-1 Bridge, which started July 1, 2026, works separately from Medicaid and applies in every state.
Has Oregon expanded Medicaid under the ACA?
Yes - Oregon has adopted Medicaid expansion, which broadens who qualifies for Medicaid coverage generally, though it does not by itself guarantee GLP-1 weight-loss coverage (see above).
Does the Oregon state employee health plan cover Wegovy or Zepbound?
No. Oregon's Public Employees' Benefit Board plans exclude weight-loss drugs: Moda's 2026 PEBB Synergy handbook (effective January 1, 2026) lists 'Weight Loss Medications' among the medications and supplies that are not covered. The Board's 2027 plan decisions (July 7, 2026 meeting) list no weight-loss drug change, though the Kaiser and Providence 2026 plan documents were not reviewed. This was checked against Oregon's own plan documents on September 20, 2026; plan terms are reset each plan year, so confirm with your plan before relying on it.